![]() |
Name |
Heptacosane
|
Molecular Formula | C27H56 | |
IUPAC Name* |
heptacosane
|
|
SMILES |
CCCCCCCCCCCCCCCCCCCCCCCCCCC
|
|
InChI |
InChI=1S/C27H56/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-26-24-22-20-18-16-14-12-10-8-6-4-2/h3-27H2,1-2H3
|
|
InChIKey |
BJQWYEJQWHSSCJ-UHFFFAOYSA-N
|
|
Synonyms |
HEPTACOSANE; n-Heptacosane; 593-49-7; VP371W2GJS; UNII-VP371W2GJS; EINECS 209-792-4; AI3-36283; QSPL 047; QSPL 073; Heptacosane, analytical standard; DTXSID6058637; CHEBI:32941; HSDB 8357; CH3-[CH2]25-CH3; Heptacosane, >=98.0% (GC); ZINC6920430; LMFA11000574; MFCD00009862; AKOS016013111; n-Heptacosane 100 microg/mL in Hexane; LS-15223; CS-0314668; FT-0626891; H0017; C16045; Q151028; 4557DE11-D8CE-461B-BBA4-5A5BBDA1A670
|
|
CAS | 593-49-7 | |
PubChem CID | 11636 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 380.7 | ALogp: | 14.2 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 24 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 27 | QED Weighted: | 0.119 |
Caco-2 Permeability: | -5.294 | MDCK Permeability: | 0.00000336 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.08 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0.005 | Plasma Protein Binding (PPB): | 100.43% |
Volume Distribution (VD): | 5.163 | Fu: | 0.82% |
CYP1A2-inhibitor: | 0.041 | CYP1A2-substrate: | 0.132 |
CYP2C19-inhibitor: | 0.117 | CYP2C19-substrate: | 0.054 |
CYP2C9-inhibitor: | 0.02 | CYP2C9-substrate: | 0.974 |
CYP2D6-inhibitor: | 0.059 | CYP2D6-substrate: | 0.017 |
CYP3A4-inhibitor: | 0.137 | CYP3A4-substrate: | 0.014 |
Clearance (CL): | 4.315 | Half-life (T1/2): | 0.009 |
hERG Blockers: | 0.47 | Human Hepatotoxicity (H-HT): | 0.004 |
Drug-inuced Liver Injury (DILI): | 0.456 | AMES Toxicity: | 0.008 |
Rat Oral Acute Toxicity: | 0.014 | Maximum Recommended Daily Dose: | 0.045 |
Skin Sensitization: | 0.977 | Carcinogencity: | 0.016 |
Eye Corrosion: | 0.997 | Eye Irritation: | 0.926 |
Respiratory Toxicity: | 0.217 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000435 | ![]() |
0.963 | D00AOJ | ![]() |
0.738 | ||
ENC000434 | ![]() |
0.962 | D00STJ | ![]() |
0.451 | ||
ENC000436 | ![]() |
0.929 | D07ILQ | ![]() |
0.448 | ||
ENC000433 | ![]() |
0.924 | D00FGR | ![]() |
0.439 | ||
ENC000443 | ![]() |
0.898 | D0Z5SM | ![]() |
0.400 | ||
ENC000446 | ![]() |
0.886 | D0O1PH | ![]() |
0.343 | ||
ENC000437 | ![]() |
0.868 | D0T9TJ | ![]() |
0.341 | ||
ENC001125 | ![]() |
0.852 | D05ATI | ![]() |
0.340 | ||
ENC000716 | ![]() |
0.851 | D0Z1QC | ![]() |
0.339 | ||
ENC001238 | ![]() |
0.851 | D01NTX | ![]() |
0.331 |